The associations of incretin hormone concentration with gestational diabetes mellitus
Background: Enteropancreatic hormonal system disorder is a possible reason for β-cell dysfunction and carbohydrate metabolism disorder among pregnant women. However, no information is available about the state of enteroinsulin hormones [glucagon, glucose-dependent insulinotropic peptide (GIP), gluca...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/152a9f78f6864022a6056a32d20297ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:152a9f78f6864022a6056a32d20297ce |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:152a9f78f6864022a6056a32d20297ce2021-11-14T09:00:20ZThe associations of incretin hormone concentration with gestational diabetes mellitus2072-03512072-037810.14341/DM2004134-37https://doaj.org/article/152a9f78f6864022a6056a32d20297ce2016-05-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7026https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background: Enteropancreatic hormonal system disorder is a possible reason for β-cell dysfunction and carbohydrate metabolism disorder among pregnant women. However, no information is available about the state of enteroinsulin hormones [glucagon, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide1 (GLP-1) and GLP-2] during pregnancy. The role of enteroinsulin hormones in the development of carbohydrate metabolism disorder during pregnancy is poorly understood. Aim: To quantify and compare incretin hormone secretion in groups of pregnant women with and without gestational diabetes mellitus (GDM). Materials and methods: The study included 80 patients, 50 of whom had GDM, and the control group consisted of 30 pregnant women without GDM. All patients underwent an oral glucose tolerance test; glycated haemoglobin (HbA1c) estimation; ferritin, transferrin, basal and postprandial glucagon estimation; GLP-1 and GLP-2 estimation. Results: Basal glucagon and GLP-1 levels were significantly higher (p <0. 05) in the group of women with GDM than in the control group. The most significant differences in GLP-1, basal and postprandial glucagon levels were observed during the first trimester of pregnancy. Conclusion: High GLP-1 levels in the group of women with GDM may reflect a state of ‘incretin resistance’, which is similar to hyperinsulinemia in the early stages of type 2 diabetes mellitus.Tatiana V. SaprinaEkaterina S. TimokhinaOlga K. GoncharevichSvetlana V. BudeevaTatiana S. ProkhorenkoLyubov A. TashirevaNadezhda N. MusinaIrina V. DronovaEndocrinology Research Centrearticlegestational diabetes mellitusincretinsglucagonglucagon-like peptide-1glucagon-like peptide-2Nutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 2, Pp 150-157 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
gestational diabetes mellitus incretins glucagon glucagon-like peptide-1 glucagon-like peptide-2 Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
gestational diabetes mellitus incretins glucagon glucagon-like peptide-1 glucagon-like peptide-2 Nutritional diseases. Deficiency diseases RC620-627 Tatiana V. Saprina Ekaterina S. Timokhina Olga K. Goncharevich Svetlana V. Budeeva Tatiana S. Prokhorenko Lyubov A. Tashireva Nadezhda N. Musina Irina V. Dronova The associations of incretin hormone concentration with gestational diabetes mellitus |
description |
Background: Enteropancreatic hormonal system disorder is a possible reason for β-cell dysfunction and carbohydrate metabolism disorder among pregnant women. However, no information is available about the state of enteroinsulin hormones [glucagon, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide1 (GLP-1) and GLP-2] during pregnancy. The role of enteroinsulin hormones in the development of carbohydrate metabolism disorder during pregnancy is poorly understood. Aim: To quantify and compare incretin hormone secretion in groups of pregnant women with and without gestational diabetes mellitus (GDM). Materials and methods: The study included 80 patients, 50 of whom had GDM, and the control group consisted of 30 pregnant women without GDM. All patients underwent an oral glucose tolerance test; glycated haemoglobin (HbA1c) estimation; ferritin, transferrin, basal and postprandial glucagon estimation; GLP-1 and GLP-2 estimation. Results: Basal glucagon and GLP-1 levels were significantly higher (p <0. 05) in the group of women with GDM than in the control group. The most significant differences in GLP-1, basal and postprandial glucagon levels were observed during the first trimester of pregnancy. Conclusion: High GLP-1 levels in the group of women with GDM may reflect a state of ‘incretin resistance’, which is similar to hyperinsulinemia in the early stages of type 2 diabetes mellitus. |
format |
article |
author |
Tatiana V. Saprina Ekaterina S. Timokhina Olga K. Goncharevich Svetlana V. Budeeva Tatiana S. Prokhorenko Lyubov A. Tashireva Nadezhda N. Musina Irina V. Dronova |
author_facet |
Tatiana V. Saprina Ekaterina S. Timokhina Olga K. Goncharevich Svetlana V. Budeeva Tatiana S. Prokhorenko Lyubov A. Tashireva Nadezhda N. Musina Irina V. Dronova |
author_sort |
Tatiana V. Saprina |
title |
The associations of incretin hormone concentration with gestational diabetes mellitus |
title_short |
The associations of incretin hormone concentration with gestational diabetes mellitus |
title_full |
The associations of incretin hormone concentration with gestational diabetes mellitus |
title_fullStr |
The associations of incretin hormone concentration with gestational diabetes mellitus |
title_full_unstemmed |
The associations of incretin hormone concentration with gestational diabetes mellitus |
title_sort |
associations of incretin hormone concentration with gestational diabetes mellitus |
publisher |
Endocrinology Research Centre |
publishDate |
2016 |
url |
https://doaj.org/article/152a9f78f6864022a6056a32d20297ce |
work_keys_str_mv |
AT tatianavsaprina theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT ekaterinastimokhina theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT olgakgoncharevich theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT svetlanavbudeeva theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT tatianasprokhorenko theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT lyubovatashireva theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT nadezhdanmusina theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT irinavdronova theassociationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT tatianavsaprina associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT ekaterinastimokhina associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT olgakgoncharevich associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT svetlanavbudeeva associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT tatianasprokhorenko associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT lyubovatashireva associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT nadezhdanmusina associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus AT irinavdronova associationsofincretinhormoneconcentrationwithgestationaldiabetesmellitus |
_version_ |
1718429510334939136 |